Enhanced Tumor Uptake and Penetration of Virotherapy using Polymer Stealthing and Focused Ultrasound
Enhanced Tumor Uptake and Penetration of Virotherapy using Polymer Stealthing and Focused Ultrasound
25 November 2021
Intellectual property
OxSonics' proprietary IP portfolio
OxSonics’ proprietary intellectual property portfolio consists of multiple patent families and a substantial body of know-how that collectively provide protection to several key elements of the SonoTran® Platform.
Patents protecting OxSonics core technology have been granted across key jurisdictions with several further patents at an advanced stage of prosecution.
